ACETYLENIC CYANOENONES AS THERAPEUTICS FOR INFLAMMATION AND CARCINOGENESIS
    1.
    发明申请
    ACETYLENIC CYANOENONES AS THERAPEUTICS FOR INFLAMMATION AND CARCINOGENESIS 审中-公开
    乙酰氨基酚作为炎症和致癌作用的治疗方法

    公开(公告)号:WO2016168450A1

    公开(公告)日:2016-10-20

    申请号:PCT/US2016/027514

    申请日:2016-04-14

    Abstract: The present invention provides a compound having the structure: wherein X is C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, cyano, aryl, heteroaryl, alkylaryl, alkylheteroaryl, alkenylaryl, alkenylheteroaryl, alkynylaryl, alkynylheteroaryl, alkoxy, alkenyloxy, alkynyloxy, aryloxy, heteroaryloxy, acyl, alkylhydroxy, alkylamino, alkenylamino, alkynylamino, amido, carboxyl, or carboxyl ester, or forms an unsubstituted or substituted cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, indane or tetralin with Y, Y is H or forms an unsubstituted or substituted cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, indane or tetralin with X, or forms an unsubstituted or substituted monocycle with Z; and Z is H or forms an unsubstituted or substituted monocycle with Y; wherein when X and Y are both H, then X is C 2 alkenyl or C 2 alkynyl, and when Y is H forms a substituted cyclohexyl, cycloheptyl with X, the cyclohexyl is other than a trisubstituted cyclohexyl bearing CH 3 , i-Pr and (CH 2 ) 2 CO 2 CH 3 groups or CH 3 , i-Pr and (CH 2 ) 3 NH 2 , or a salt or ester thereof.

    Abstract translation: 本发明提供具有以下结构的化合物:其中X为C1-C12烷基,C2-C12烯基,C2-C12炔基,氰基,芳基,杂芳基,烷基芳基,烷基杂芳基,烯基芳基,烯基杂芳基,炔基芳基,炔基杂芳基,烷氧基,烯氧基, 或者与Y形成未取代或取代的环丁基,环戊基,环己基,环庚基,二氢化萘或四氢化萘,Y是H或形成一个或多个环烷基,环烷基,环烷基,环烷基, 未取代或取代的环丁基,环戊基,环己基,环庚基,二氢化茚或四氢萘与X,或与Z形成未取代或取代的单环; 并且Z是H或与Y形成未取代或取代的单环; 其中当X和Y均为H时,则X为C 2烯基或C 2炔基,Y为H时,X与X形成取代的环己基环庚基,环己基除三取代的含有CH 3,i-Pr和(CH 2) 2 CO 2 CH 3基团或CH 3,i-Pr和(CH 2)3 NH 2,或其盐或酯。

    A NOVEL METHOD FOR SYNTHESIZING TBE-31
    2.
    发明申请
    A NOVEL METHOD FOR SYNTHESIZING TBE-31 审中-公开
    一种合成TBE-31的新方法

    公开(公告)号:WO2014151181A1

    公开(公告)日:2014-09-25

    申请号:PCT/US2014/025172

    申请日:2014-03-13

    Abstract: A process for the synthesis of (±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10,10a-octahydrophenanthrene-2,6-dicarbonitrile ("TBE-31"), which is useful for the treatment of various diseases and disorder in mammals. (±)-8a-(Hydroxymethyl)-1,4a-dimethyl-2,3,4,4a,6,7,8,8a,9,10-decahydrophenanthren-2-ol; (±)-8a-(Hydroxymethyl)-1,4a-dimethyl-4,4a,6,7,8,8a,9,10-octahydrophenanthren-2(3H)-one; (±)-(2R,4aS,8aS)-8a-(Hydroxymethyl)-1,4a-dimethyl-2,3,4,4a,6,7,8,8a,9,10-decahydrophenanthren-2-ol; (±)-(2S,4aS,8aS)-8a-(Hydroxymethyl)-1,4a-dimethyl-2,3,4,4a,6,7,8,8a,9,10-decahydrophenanthren-2-ol; and (±)-(4aS,8aS)-8a-(Hydroxymethyl)-1,4a-dimethyl-4,4a,6,7,8,8a,9,10-octahydrophenanthren-2(3H)-one (4).

    Abstract translation: 合成(±) - (4bS,8aR,10aS)-10a-乙炔基-4,4,8,8-三甲基-3,7-二氧代-3,4b,7,8,8a,9,10, 10a-八氢菲-2,6-二腈(“TBE-31”),其可用于治疗哺乳动物的各种疾病和病症。 (±)-8a-(羟基甲基)-1,4a二甲基甲基-2,3,4,4a,6,7,8,8a,9,10- decahydrophenanthren -2-醇; (±)-8a-(羟基甲基)-1,4a二甲基甲基-4,4a,6,7,8,8a,9,10- octahydrophenanthren -2(3H) - 酮; (±) - (2R,4AS,8AS)-8a-(羟基甲基)-1,4a二甲基甲基-2,3,4,4a,6,7,8,8a,9,10- decahydrophenanthren -2-醇; (±) - (2S,4AS,8AS)-8a-(羟基甲基)-1,4a二甲基甲基-2,3,4,4a,6,7,8,8a,9,10- decahydrophenanthren -2-醇; 和(±) - (4aS,8aS)-8a-(羟甲基)-1,4a-二甲基-4,4a,6,7,8,8a,9,10-八氢菲-2(3H) - 酮(4) 。

Patent Agency Ranking